PTV - PET traced volume?

NuklearMedizin

Volumn 48, Issue 4, 2009, Pages 127-129

  Nestle, U ^a   Kotzerke, Jörg ^b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; FLUORODEOXYGLUCOSE; RADIOACTIVE MATERIAL; TRACER; DIAGNOSTIC AGENT; FLUORODEOXYGLUCOSE F 18;

CANCER DIAGNOSIS; COMPUTER ASSISTED TOMOGRAPHY; DIFFUSION TENSOR IMAGING; DISEASE SEVERITY; EDITORIAL; EXTERNAL BEAM RADIOTHERAPY; GLYCOLYSIS; HUMAN; IRRADIATION; NEOPLASM; NUCLEAR MEDICINE; ONCOLOGY; POSITRON EMISSION TOMOGRAPHY; PROGNOSIS; RADIATION DOSE; RADIATION HAZARD; RADIOLOGY; TUMOR LOCALIZATION; TUMOR VOLUME; BRAIN TUMOR; METHODOLOGY; PATHOLOGY; SCINTISCANNING;

BRAIN NEOPLASMS; FLUORODEOXYGLUCOSE F18; HUMANS; NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY;

EID: 70349196477     PISSN: 00295566     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1621107     Document Type: Editorial

References (22)

1. 18F)fluoro-L-DOPA and PET. Nuklearmedizin 2008; 47: 200-204.
2. 18F)-TOCA positron emission tomography. Int J Radiat Oncol Biol Phys 2009; 73: 1135-1140.
3. 11C-methionine-positron emission tomography on gross tumor volume delineation in stereotactic radiotherapy of skull base meningiomas. Int J Radiat Oncol Biol Phys 2008; 72: 1161-1167.
4. Black QC, Grills IS, Kestin LL et al. Defining a radiotherapy target with positron emission tomography. Int J Radiat Oncol Biol Phys 2004; 60: 1272-1282. (Pubitemid 39440814)
5. 18FDG-hybrid PET fusion. Int J Radiat Oncol Biol Phys 2001; 51: 923-931.
6. Eckardt J, Herzog H, Schäfers KP et al. Impact of the lower energy threshold on the NEMA NU2-2001 count-rate performance of a LSO based PET-CT scanner. Nuklearmedizin 2008; 47: 210-214.
7. Fryback DG, Thornbury JR. The efficacy of diagnostic imaging. Med Decis Making 1991; 11: 88-94.
8. Grosu AL, Weber WA, Franz M et al. Reirradiation of recurrent high-grade gliomas using amino acid PET (SPECT)/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy. Int J Radiat Oncol Biol Phys 2005; 63: 511-519. (Pubitemid 41317169)
9. Krause BJ, Beyer T, Bockisch A et al. FDG-PET/CT in oncology. German Guideline. Nuklearmedizin 2007; 46: 291-301.
10. Krohn T, Kaiser HJ, Gagel B et al. 3D volume and SUV analysis of oncological PET studies: a voxelbased image processing tool with NSCLC as example). Nuklearmedizin 2007; 46: 141-148. (Pubitemid 47356537)
11. Ling CC, Humm J, Larson S et al. Towards multi-dimensional radiotherapy (MD-CRT): biological imaging and biological conformality. Int J Radiat Oncol Biol Phys 2000; 47: 551-560. (Pubitemid 30317470)
12. Macmanus M, Nestle U, Rosenzweig KE et al. Use of PET and PET/CT for Radiation Therapy Planning: IAEA expert report 2006-2007. Radiother Oncol 2009; 91: 85-94.
13. Macmanus MP, Hicks RJ. Where do we draw the line? Contouring tumors on positron emission tomography/computed tomography. Int J Radiat Oncol Biol Phys 2008; 71: 2-4.
14. Nestle U, Kremp S, Grosu AL. Practical integration of 18F-FDG-PET and PET-CT in the planning of radiotherapy for non-small cell lung cancer (NSCLC): the technical basis, ICRU-target volumes, problems, perspectives. Radiother Oncol 2006; 81: 209-225. (Pubitemid 44780785)
15. Nestle U, Kremp S, Schaefer-Schuler A et al. Comparison of different methods for delineation of 18F-FDG PET-positive tissue for target volume definition in radiotherapy of patients with nonsmall cell lung cancer. J Nucl Med 2005; 46: 1342-1348. (Pubitemid 43733485)
16. Nestle U, Schaefer-Schuler A, Kremp S et al. Target volume definition for 18F-FDG PET-positive lymph nodes in radiotherapy of patients with non-small cell lung cancer. Eur J Nucl Med Mol Imaging 2007; 34: 453-462. (Pubitemid 46426982)
17. Nestle U, Weber W, Hentschel M, Grosu AL. Biological imaging in radiation therapy: role of positron emission tomography. Phys Med Biol 2009; 54: R1-25.
18. Steenbakkers RJ, Duppen JC, Fitton I et al. Reduction of observer variation using matched CT-PET for lung cancer delineation: a three-dimensional analysis. Int J Radiat Oncol Biol Phys 2006; 64: 435-448. (Pubitemid 43083430)
19. Stergar H, Bockisch A, Eschmann SM et al. Influence of PET/CT-introduction on PET scanning frequency and indications. Results of a multicenter study. Nuklearmedizin 2007; 46: 57-64.
20. van Baardwijk A, Bosmans G, Boersma L et al. PETCT-based auto-contouring in non-small-cell lung cancer correlates with pathology and reduces interobserver variability in the delineation of the primary tumor and involved nodal volumes. Int J Radiat Oncol Biol Phys 2007; 68: 771-778. (Pubitemid 46818730)
21. Weber WA, Grosu AL, Czernin J. Technology Insight: advances in molecular imaging and an appraisal of PET/CT scanning. Nat Clin Pract Oncol 2008; 5: 160-170.
22. Wolz G, Nomayr A, Hothorn T et al. Anatomical accuracy of interactive and automated rigid registration between X-ray CT and FDG-PET. Nuklearmedizin 2007; 46: 43-48. (Pubitemid 46374432)